MeSH tree: C12.100.500.260
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic's Department of Radiation Oncology developed the PSA ...
Jan 15, 2026
0
7
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models. The tool, tested on over ...
Jan 12, 2026
0
13
Eating some common food preservatives is linked to a slightly higher risk of eventually developing cancer and diabetes, according to two large French studies published Thursday.
Jan 11, 2026
0
59
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.
Jan 7, 2026
0
18
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after treatment, particularly ...
Dec 19, 2025
0
14
The precise identification of tumor boundaries during radical prostatectomy remains a major clinical challenge. As positive surgical margins occur in 15–40% of prostate cancer cases, the risk of postoperative recurrence and ...
Nov 24, 2025
0
14
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.
Nov 20, 2025
0
19
New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and treatment for patients of African ...
Nov 5, 2025
0
11
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate cancer. In a systematic CRISPR screen, scientists from Arc Institute, UCSF, and the Fred Hutchinson ...
Nov 5, 2025
0
39
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...
Nov 4, 2025
0
19
